Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $77,481 | 23 | 55.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $57,350 | 45 | 40.9% |
| Travel and Lodging | $2,515 | 9 | 1.8% |
| Food and Beverage | $1,730 | 23 | 1.2% |
| Education | $980.00 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $62,294 | 50 | $0 (2021) |
| ACADIA Pharmaceuticals Inc | $27,000 | 2 | $0 (2022) |
| Eli Lilly and Company | $14,943 | 10 | $0 (2022) |
| Novo Nordisk Inc | $12,201 | 13 | $0 (2022) |
| Eisai Inc. | $8,045 | 12 | $0 (2019) |
| Lilly USA, LLC | $5,103 | 8 | $0 (2024) |
| Roche Products Limited | $4,320 | 3 | $0 (2021) |
| Genentech, Inc. | $3,000 | 1 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $1,710 | 1 | $0 (2021) |
| F. Hoffmann-La Roche AG | $1,440 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $368.76 | 1 | Lilly USA, LLC ($368.76) |
| 2023 | $18.75 | 1 | Lilly USA, LLC ($18.75) |
| 2022 | $19,982 | 11 | Novo Nordisk Inc ($8,407) |
| 2021 | $81,316 | 54 | Biogen, Inc. ($51,553) |
| 2020 | $12,524 | 7 | Biogen, Inc. ($6,164) |
| 2019 | $12,593 | 13 | Eisai Inc. ($8,045) |
| 2018 | $28.07 | 1 | Biogen, Inc. ($28.07) |
| 2017 | $13,225 | 13 | Eli Lilly and Company ($8,509) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/11/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $368.76 | General |
| 04/10/2023 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Neuroscience | ||||||
| 06/15/2022 | ACADIA Pharmaceuticals Inc | — | Consulting Fee | Cash or cash equivalent | $8,000.00 | General |
| 06/07/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $28.18 | General |
| 06/06/2022 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $4,913.00 | General |
| 06/06/2022 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $597.61 | General |
| 06/06/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $392.83 | General |
| 06/06/2022 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $281.25 | General |
| 06/06/2022 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $190.84 | General |
| 06/05/2022 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,955.00 | General |
| 04/06/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.70 | General |
| 03/08/2022 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $3,575.00 | General |
| 02/04/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $33.65 | General |
| 11/30/2021 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,130.00 | General |
| 11/18/2021 | Biogen, Inc. | ADUHELM (Biological) | Consulting Fee | Cash or cash equivalent | $1,130.00 | General |
| Category: NEUROLOGY | ||||||
| 11/17/2021 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 11/09/2021 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $108.58 | General |
| 10/25/2021 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| 06/16/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $53.54 | General |
| 06/11/2021 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,130.00 | General |
| 05/26/2021 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,360.00 | General |
| 05/25/2021 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,130.00 | General |
| 05/25/2021 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $680.00 | General |
| 05/24/2021 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,130.00 | General |
| 05/21/2021 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,130.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 36 | 45 | $26,420 | $5,438 |
| 2020 | 3 | 60 | 78 | $47,050 | $8,803 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 31 | $15,500 | $4,146 | 26.7% |
| 96132 | Neuropsychological testing evaluation by qualified health care professional, first 60 minutes | Office | 2021 | 12 | 14 | $10,920 | $1,292 | 11.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 26 | 40 | $20,000 | $5,386 | 26.9% |
| 96132 | Neuropsychological testing evaluation by qualified health care professional, first 60 minutes | Office | 2020 | 20 | 24 | $18,720 | $2,210 | 11.8% |
| 96133 | Neuropsychological testing evaluation by qualified health care professional, additional 60 minutes | Office | 2020 | 14 | 14 | $8,330 | $1,208 | 14.5% |
About Dr. Richard Isaacson, M.D
Dr. Richard Isaacson, M.D is a Neurology healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124056932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Isaacson, M.D has received a total of $140,056 in payments from pharmaceutical and medical device companies, with $368.76 received in 2024. These payments were reported across 101 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($77,481).
As a Medicare-enrolled provider, Isaacson has provided services to 96 Medicare beneficiaries, totaling 123 services with total Medicare billing of $14,242. Data is available for 2 years (2020–2021), covering 5 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Boca Raton, FL
- Active Since 06/29/2006
- Last Updated 07/30/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1124056932
Products in Payments
- ADUHELM (Biological) $1,130
- AMYVID (Drug) $18.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Boca Raton
Dr. Stuart Isaacson, Md, MD
Neurology — Payments: $4.9M
Brian Steingo, Md, MD
Neurology — Payments: $1.4M
Dr. Brian Costell, M.d, M.D
Neurology — Payments: $638,608
Dr. Patricio Espinosa, Md,Mph, MD,MPH
Neurology — Payments: $215,050
Gediminas Gliebus, M.d, M.D
Neurology — Payments: $120,507
Dr. Richard Dewey, Md, MD
Neurology — Payments: $45,477